A retrospective, multicenter, observational study of efficacy of ceftolozane-tazobactam (C/T) for treating infections due to Pseudomonas aeruginosa ( P. aeruginosa ) in critically ill patients
Latest Information Update: 29 Sep 2021
At a glance
- Drugs Ceftolozane/tazobactam (Primary)
- Indications Bacterial infections; Gram-negative infections; Intra-abdominal infections; Nosocomial pneumonia; Pseudomonal infections; Urinary tract infections
- Focus Adverse reactions; Therapeutic Use
- 29 Sep 2021 New trial record